EUBGD Financials
This page shows EUBGD (EUBGD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
High-margin, low-reinvestment economics let EUBGD turn a modest revenue base into steadily expanding, cash-heavy balance-sheet growth.
The earlier profit-to-cash mismatch has reversed: operating cash flow of$2.5M exceeded net income of$1.9M , so recent earnings were backed by collections rather than mainly by accruals. That helps explain why the company could absorb a prior$2.2M cash distribution and still finish with a larger liquidity cushion instead of leaning on outside capital.
The balance sheet is cash-dominant: cash and equivalents of
EUBGD’s economic engine is unusually light on direct costs, with gross margin still at
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of EUBGD's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
EUBGD has an operating margin of 51.9%, meaning the company retains $52 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 48.9% the prior year.
EUBGD's revenue grew 7.7% year-over-year to $5.7M, a solid pace of expansion. This earns a growth score of 26/100.
EUBGD carries a low D/E ratio of 0.17, meaning only $0.17 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 8.82, EUBGD holds $8.82 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
EUBGD converts 42.3% of revenue into free cash flow ($2.4M). This strong cash generation earns a score of 100/100.
EUBGD's ROE of 18.3% shows moderate profitability relative to equity, earning a score of 54/100. This is up from 17.7% the prior year.
EUBGD passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, EUBGD generates $1.32 in operating cash flow ($2.5M OCF vs $1.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
EUBGD generated $5.7M in revenue in fiscal year 2025. This represents an increase of 7.7% from the prior year.
EUBGD's EBITDA was $3.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 13.3% from the prior year.
EUBGD reported $1.9M in net income in fiscal year 2025. This represents an increase of 28.1% from the prior year.
EUBGD earned $0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Cash & Balance Sheet
EUBGD generated $2.4M in free cash flow in fiscal year 2025, representing cash available after capex.
EUBGD held $11.0M in cash against $0 in long-term debt as of fiscal year 2025.
EUBGD had 170M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
EUBGD's gross margin was 88.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.3 percentage points from the prior year.
EUBGD's operating margin was 51.9% in fiscal year 2025, reflecting core business profitability. This is up 2.9 percentage points from the prior year.
EUBGD's net profit margin was 33.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.3 percentage points from the prior year.
EUBGD's ROE was 18.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the prior year.
Capital Allocation
EUBGD invested $117K in capex in fiscal year 2025, funding long-term assets and infrastructure.
EUBGD Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $738K-68.7% | $2.4M+93.8% | $1.2M+6.5% | $1.1M+18.8% | $962K-10.9% | $1.1M-35.3% | $1.7M+32.1% | $1.3M |
| Cost of Revenue | $144K-35.7% | $224K+62.9% | $137K+2.1% | $134K-22.0% | $172K-2.5% | $177K-1.5% | $179K+5.7% | $170K |
| Gross Profit | $594K-72.2% | $2.1M+97.7% | $1.1M+7.1% | $1.0M+27.7% | $790K-12.6% | $903K-39.4% | $1.5M+36.2% | $1.1M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $590K-22.2% | $758K+96.3% | $386K-16.4% | $462K+0.2% | $461K-34.3% | $702K+65.1% | $425K-6.6% | $456K |
| Operating Income | $4K-99.7% | $1.4M+98.4% | $694K+27.0% | $547K+66.4% | $329K+63.5% | $201K-81.1% | $1.1M+66.8% | $639K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $143K-76.7% | $614K+112.6% | $289K+2.6% | $282K+43.2% | $197K-38.3% | $319K-23.1% | $414K+44.6% | $286K |
| Net Income | $78K-91.4% | $904K+128.7% | $395K-6.6% | $423K+130.5% | $183K+195.7% | $62K-91.2% | $704K+101.9% | $348K |
| EPS (Diluted) | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 |
EUBGD Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.7M-4.2% | $12.2M+18.9% | $10.3M+6.0% | $9.7M+2.6% | $9.5M+0.8% | $9.4M | N/A | N/A |
| Current Assets | $11.2M-4.8% | $11.7M+15.0% | $10.2M+6.3% | $9.6M+2.8% | $9.3M+1.0% | $9.2M | N/A | N/A |
| Cash & Equivalents | $10.6M-3.7% | $11.0M+15.2% | $9.6M+4.5% | $9.2M+2.7% | $8.9M+5.0% | $8.5M+2.6% | $8.3M-17.5% | $10.0M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $408K-26.8% | $558K+9.9% | $507K+36.1% | $373K+17.8% | $316K-35.6% | $491K | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.2M-33.6% | $1.8M+125.6% | $795K+15.6% | $687K-20.6% | $865K-11.5% | $977K | N/A | N/A |
| Current Liabilities | $960K-27.7% | $1.3M+132.8% | $570K+10.5% | $516K-6.6% | $553K-13.7% | $640K | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $10.5M+0.8% | $10.4M+10.0% | $9.5M+5.3% | $9.0M+4.9% | $8.6M+2.2% | $8.4M-0.4% | $8.4M-13.7% | $9.8M |
| Retained Earnings | $3.6M+2.2% | $3.5M+34.7% | $2.6M+17.9% | $2.2M+23.6% | $1.8M+11.4% | $1.6M | N/A | N/A |
EUBGD Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$321K-121.1% | $1.5M+356.2% | $334K+38.7% | $241K-43.3% | $424K+40.9% | $301K+3.4% | $291K-17.0% | $351K |
| Capital Expenditures | $43K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | -$364K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$93K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | $0 | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | $0 | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EUBGD Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 80.5%-10.0pp | 90.5%+1.8pp | 88.7%+0.5pp | 88.2%+6.2pp | 82.1%-1.6pp | 83.6%-5.6pp | 89.3%+2.7pp | 86.6% |
| Operating Margin | 0.5%-57.9pp | 58.4%+1.4pp | 57.0%+9.2pp | 47.8%+13.7pp | 34.2%+15.6pp | 18.6%-45.2pp | 63.8%+13.3pp | 50.5% |
| Net Margin | 10.5%-27.7pp | 38.3%+5.8pp | 32.4%-4.5pp | 37.0%+17.9pp | 19.1%+13.3pp | 5.8%-36.4pp | 42.1%+14.6pp | 27.6% |
| Return on Equity | 0.7%-7.9pp | 8.7%+4.5pp | 4.2%-0.5pp | 4.7%+2.6pp | 2.1%+1.4pp | 0.7%-7.6pp | 8.3%+4.8pp | 3.6% |
| Return on Assets | 0.7%-6.7pp | 7.4%+3.5pp | 3.8%-0.5pp | 4.4%+2.4pp | 1.9%+1.3pp | 0.7% | N/A | N/A |
| Current Ratio | 11.62+2.8 | 8.82-9.0 | 17.86-0.7 | 18.56+1.7 | 16.85+2.5 | 14.40 | N/A | N/A |
| Debt-to-Equity | 0.11-0.1 | 0.17+0.1 | 0.080.0 | 0.08-0.0 | 0.10-0.0 | 0.12 | N/A | N/A |
| FCF Margin | -49.3% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
What is EUBGD's annual revenue?
EUBGD (EUBGD) reported $5.7M in total revenue for fiscal year 2025. This represents a 7.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is EUBGD's revenue growing?
EUBGD (EUBGD) revenue grew by 7.7% year-over-year, from $5.3M to $5.7M in fiscal year 2025.
Is EUBGD profitable?
Yes, EUBGD (EUBGD) reported a net income of $1.9M in fiscal year 2025, with a net profit margin of 33.5%.
What is EUBGD's EBITDA?
EUBGD (EUBGD) had EBITDA of $3.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is EUBGD's gross margin?
EUBGD (EUBGD) had a gross margin of 88.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is EUBGD's operating margin?
EUBGD (EUBGD) had an operating margin of 51.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is EUBGD's net profit margin?
EUBGD (EUBGD) had a net profit margin of 33.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is EUBGD's return on equity (ROE)?
EUBGD (EUBGD) has a return on equity of 18.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is EUBGD's free cash flow?
EUBGD (EUBGD) generated $2.4M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is EUBGD's operating cash flow?
EUBGD (EUBGD) generated $2.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are EUBGD's total assets?
EUBGD (EUBGD) had $12.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are EUBGD's capital expenditures?
EUBGD (EUBGD) invested $117K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is EUBGD's current ratio?
EUBGD (EUBGD) had a current ratio of 8.82 as of fiscal year 2025, which is generally considered healthy.
What is EUBGD's debt-to-equity ratio?
EUBGD (EUBGD) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is EUBGD's return on assets (ROA)?
EUBGD (EUBGD) had a return on assets of 15.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is EUBGD's Piotroski F-Score?
EUBGD (EUBGD) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are EUBGD's earnings high quality?
EUBGD (EUBGD) has an earnings quality ratio of 1.32x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is EUBGD?
EUBGD (EUBGD) scores 80 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.